Search

everythinglearnresearchcommunity

for

Search:↓

ASLAN004 was safe and well-tolerated, supporting further development for treating certain diseases.

Biologics, especially Dupilumab, are effective and safe for treating severe childhood eczema.

Fremanezumab effectively reduces migraines and improves quality of life with mild side effects.

Dupilumab effectively treated severe alopecia areata in a child.

Dupilumab improved severe atopic dermatitis in a patient who didn't respond to other treatments.

TAGX-0003 protected hair follicles and reversed alopecia areata in a mouse model.

Talquetamab may cause hair loss and skin issues.

Teriflunomide is effective and generally safe for treating relapsing multiple sclerosis, reducing relapse rates and disability progression.

Mefloquine, an antimalarial drug, is effective in killing melanoma cells resistant to other treatments by causing lethal stress in the cells.

Tildrakizumab showed limited effectiveness in treating chronic alopecia areata in a small group of patients.

Aggressive immunosuppressive treatment improved a woman's severe heart condition linked to autoimmune disease.

Mycophenolate mofetil is safer and more effective than cyclophosphamide for treating lupus nephritis.

A comprehensive approach to educating patients and managing side effects is crucial for improving adherence to multiple sclerosis treatments and patient quality of life.

Treatment with prednisolone and dapsone stopped new blisters and partially healed previous ones.

Mycophenolate mofetil is effective for treating severe lupus nephritis in children.

Infliximab can cause SAPHO syndrome, which may improve with Spesolimab and methotrexate.

Co-trimoxazole may help treat autoimmune diseases.

A young woman had a rare skin reaction to a medication for her joint disease, and a combination therapy improved her condition.

Omalizumab may cause hair loss.

Brodalumab effectively treated a man's severe hand and foot psoriasis.

Risankizumab effectively treats and maintains skin clearance in moderate-to-severe psoriasis.

A woman with severe hair loss was successfully treated with the drug adalimumab.

Teriflunomide effectively reduces relapses and disability in MS and has a manageable safety profile.

Teriflunomide is effective and generally safe for treating relapsing-remitting multiple sclerosis.

Dupilumab helped improve skin and prevent new lesions in a child with a rare immune disorder and severe eczema.

A woman with a rare autoimmune disorder had a blister on her eye and unique immune reaction, which was effectively treated with medication.

Biologic therapies can cause various adverse events, but allergy/immunology clinicians can manage them.

Safusidenib erbumine shows promise as a treatment for certain brain tumors, but mild side effects like hair loss need attention.

New treatments for relapsing multiple sclerosis are more effective and convenient but have higher risks of serious side effects.

Omalizumab can cause temporary hair loss but still works well for chronic urticaria.